News | Mammography | April 07, 2016

System donated by Fujifilm and National Breast Cancer Foundation will assist radiologists in screening and diagnosis of breast cancer

White Memorial Medical Center, Los Angeles, Fujifilm, Aspire Cristalle mammography system, NBCF, install

April 7, 2016 — In late March, White Memorial Medical Center in downtown Los Angeles celebrated the installation of a new Fujifilm Aspire Cristalle mammography system. The system was donated to the 353-bed hospital, a member of the Adventist Health System, by Fujifilm Medical Systems U.S.A. and the National Breast Cancer Foundation.

According to the National Cancer Institute, 1 in 8 women will be diagnosed with breast cancer in their lifetime. Early detection and treatment are among the most effective ways to overcome cancer. The latest technology at White Memorial Medical Center will assist radiologists in screening and diagnosis of breast cancer.

“The incredible support we receive from National Breast Cancer Foundation makes a big difference at White Memorial Medical Center,” said John Raffoul, president and CEO, White Memorial Medical Center. “This year alone, thanks to support from NBCF and other generous donors, we will be able to provide more than 2,300 free clinical breast exams/mammograms to underserved women of our community, of whom 45 will unfortunately test positive for cancer. This state-of-the-art equipment from Fujifilm will literally allow us to save the lives of women when we can diagnose them at an early stage of breast cancer. We are blessed to have these incredible partners supporting our hospital.”

Since 2006, Fujifilm has donated $1.6 million to NBCF.  The support has allowed NBCF to provide thousands of mammograms and early detection services to women in all 50 states and helped ensure that those facing breast cancer have access to quality healthcare.

For more information: www.fujifilmhealthcare.com


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | Ultrasound Women's Health

Sept. 29, 2026 — A research team at the University of Virginia (UVA) led by Timothy Bullock, PhD, has published results ...

Time September 30, 2026
arrow
News | Women's Health

Sept. 1, 2026 — On Sept. 24, 2026 at 1 p.m. EDT, Siemens Healthineers will present a webinar on "Advancing Women's ...

Time September 03, 2026
arrow
Subscribe Now